Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Other Non-current Assets
Long-term assets not reported separately.
Beta Bionics, Inc.NASDAQ: BBNX
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets falls 26.4% from a year ago
Other non-current assets stood at $181K at the end of Q1 FY2026, down 26.4% from a year earlier and up 0.6% from the prior quarter. Over 3 fiscal years it compounded at -2.3% a year.
Context
- Other non-current assets amounted to 0.1% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -26.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 180K USD
- Year-over-year change
- -96.6%
- 3-year CAGR
- -2.3%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 180K | -96.6% |
| FY2024 | 2024-12-31 | 5.3M | +2298.6% |
| FY2023 | 2023-12-31 | 221K | +14.5% |
| FY2022 | 2022-12-31 | 193K | — |
Other Non-current Assets vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -26.4% is the 5th highest of 7, against a peer median of -3.6%.
- Other non-current assets amounts to 0.1% of total assets for BBNX, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 6.43B DKK | +44.8% | +205.3% | 1.1% | |
| Jun 2026 | $271.6M USD | -14.8% | -3.2% | 8.6% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $135M USD | — | — | 2.9% |
| Jun 2026 | $64.2M USD | +7.5% | +29.3% | 1.0% | |
| Mar 2026 | $30.82M USD | +312.9% | +6.4% | 2.7% | |
| Mar 2026 | $10.72M USD | -62.8% | +227.2% | 1.4% | |
| Mar 2026 | $181K USD | -26.4% | -2.3% | 0.1% | |
| Mar 2026 | $48K USD | -98.9% | +371.8% | 0.0% | |
| Peer median (excluding BBNX) | — | -3.6% | +117.3% | 1.4% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.